Strengthening regulatory oversight & boosting clinical trial capacity in Africa

Vaccine Insights 2022; 1(3), 145–147

DOI: 10.18609/vac.2022.024

Published: 15 July 2022
Viewpoint
Bartholomew Dicky Akanmori

“AVAREF should be recognized as a regional platform that offers developers the opportunity to conduct clinical trials to international standards.”

An increasing number of vaccine clinical trials have been carried out in Africa over the last 20 years. Through initiatives like the African Vaccine Regulatory Forum, clinical trial capacity has increased greatly – but we must not stop here. Continuing to build clinical trial capacity must be recognized as a critical goal for African nations.